Cargando…

Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis

BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (AAGN) is characterized by rapidly progressive glomerulonephritis, and timely initiation of treatment and evaluation is critical to prevent the progression of renal disease to end-stage renal disease (ESRD). The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruiqiang, Zhang, Xiaofeng, Wang, Xinfang, Chen, Lin, Ma, Qiuling, Su, Yajing, Liu, Jingwen, Shi, Huihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169502/
https://www.ncbi.nlm.nih.gov/pubmed/37161465
http://dx.doi.org/10.1186/s40001-023-01113-7
_version_ 1785039054730952704
author Wang, Ruiqiang
Zhang, Xiaofeng
Wang, Xinfang
Chen, Lin
Ma, Qiuling
Su, Yajing
Liu, Jingwen
Shi, Huihui
author_facet Wang, Ruiqiang
Zhang, Xiaofeng
Wang, Xinfang
Chen, Lin
Ma, Qiuling
Su, Yajing
Liu, Jingwen
Shi, Huihui
author_sort Wang, Ruiqiang
collection PubMed
description BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (AAGN) is characterized by rapidly progressive glomerulonephritis, and timely initiation of treatment and evaluation is critical to prevent the progression of renal disease to end-stage renal disease (ESRD). The aim of this study was to evaluate predictive value of the renal risk score (RRS), Birmingham vasculitis activity score (BVAS), and renal vascular lesions (RVLs) score for renal prognosis in AAGN. METHODS: A retrospective analysis of ninety-four patients diagnosed with AAGN after renal biopsy was performed. The RRS, BVAS, and RVLs score were evaluated in relation to clinicopathologic features and renal prognosis. A receiver operating characteristic curve (ROC) was used to evaluate their renal prognostic value. RESULTS: The median follow-up time was 36 months. Thirty-eight patients progressed to ESRD. Survival analysis showed that renal prognosis worsened in the RRS group in order of low, medium, and high RRS (P < 0.05). Within the RVLs group, the renal prognosis of the groups with severe and moderate RVLs was worse than that of the group without RVLs (P = 0.012, P < 0.001), and the group with mild RVLs was close to that of the group without RVLs. ROC analysis showed that the AUC of RRS, BVAS, RVLs score, RVLs score combined with RRS (RVLs score & RRS, RR), RVLs score, and RRS combined with BVAS (RVLs score & RRS & BVAS, RRB) were 0.865, 0.624, 0.763, 0.910, and 0.942, respectively. The predictive power of RRB and RR was comparable and significantly better than the RRS, BVAS, and RVLs score. Based on simplicity and validity, RR was selected as the best predictor, and the relationship between RRS, RVLs score, and RR was calculated using a linear fit, resulting in the linear equation RR = -0.4766 + 0.1231 × RVLs score + 0.395 × RRS (P < 0.001). CONCLUSIONS: In AAGN, the predictive power of RR for renal prognosis was superior to that of RRS, BVAS, and RVLs score. RR may serve as a new predictor of renal prognosis in AAGN.
format Online
Article
Text
id pubmed-10169502
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101695022023-05-11 Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis Wang, Ruiqiang Zhang, Xiaofeng Wang, Xinfang Chen, Lin Ma, Qiuling Su, Yajing Liu, Jingwen Shi, Huihui Eur J Med Res Research BACKGROUND: Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (AAGN) is characterized by rapidly progressive glomerulonephritis, and timely initiation of treatment and evaluation is critical to prevent the progression of renal disease to end-stage renal disease (ESRD). The aim of this study was to evaluate predictive value of the renal risk score (RRS), Birmingham vasculitis activity score (BVAS), and renal vascular lesions (RVLs) score for renal prognosis in AAGN. METHODS: A retrospective analysis of ninety-four patients diagnosed with AAGN after renal biopsy was performed. The RRS, BVAS, and RVLs score were evaluated in relation to clinicopathologic features and renal prognosis. A receiver operating characteristic curve (ROC) was used to evaluate their renal prognostic value. RESULTS: The median follow-up time was 36 months. Thirty-eight patients progressed to ESRD. Survival analysis showed that renal prognosis worsened in the RRS group in order of low, medium, and high RRS (P < 0.05). Within the RVLs group, the renal prognosis of the groups with severe and moderate RVLs was worse than that of the group without RVLs (P = 0.012, P < 0.001), and the group with mild RVLs was close to that of the group without RVLs. ROC analysis showed that the AUC of RRS, BVAS, RVLs score, RVLs score combined with RRS (RVLs score & RRS, RR), RVLs score, and RRS combined with BVAS (RVLs score & RRS & BVAS, RRB) were 0.865, 0.624, 0.763, 0.910, and 0.942, respectively. The predictive power of RRB and RR was comparable and significantly better than the RRS, BVAS, and RVLs score. Based on simplicity and validity, RR was selected as the best predictor, and the relationship between RRS, RVLs score, and RR was calculated using a linear fit, resulting in the linear equation RR = -0.4766 + 0.1231 × RVLs score + 0.395 × RRS (P < 0.001). CONCLUSIONS: In AAGN, the predictive power of RR for renal prognosis was superior to that of RRS, BVAS, and RVLs score. RR may serve as a new predictor of renal prognosis in AAGN. BioMed Central 2023-05-09 /pmc/articles/PMC10169502/ /pubmed/37161465 http://dx.doi.org/10.1186/s40001-023-01113-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Ruiqiang
Zhang, Xiaofeng
Wang, Xinfang
Chen, Lin
Ma, Qiuling
Su, Yajing
Liu, Jingwen
Shi, Huihui
Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
title Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
title_full Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
title_fullStr Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
title_full_unstemmed Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
title_short Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
title_sort evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169502/
https://www.ncbi.nlm.nih.gov/pubmed/37161465
http://dx.doi.org/10.1186/s40001-023-01113-7
work_keys_str_mv AT wangruiqiang evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT zhangxiaofeng evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT wangxinfang evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT chenlin evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT maqiuling evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT suyajing evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT liujingwen evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis
AT shihuihui evaluationofthreescoringsystemsforpredictingrenalprognosisinantineutrophilcytoplasmicantibodyassociatedglomerulonephritis